February 2015 Research Highlights
In this Breastcancer.org podcast, Dr. Brian Wojciechowski discusses Ibrance, a medicine that was approved to treat metastatic, hormone-receptor-positive breast cancer in February 2015.
Listen to the podcast to hear Dr. Wojciechowski explain:
how Ibrance works
who is eligible to take Ibrance
how Ibrance is taken and whether any other medicines are taken with it
the side effects that Ibrance can cause
Dr. Wojo is a medical oncologist outside of Philadelphia, PA, with Crozer Health. His research has been presented at the San Antonio Breast Cancer Symposium, and he is a speaker on medical ethics and the biology of cancer. Dr. Wojo sees cancer as a scientifically complex disease with psychological, social, and spiritual dimensions.
— Last updated on May 2, 2022, 2:44 PM